HOME >> BIOLOGY >> NEWS
New guidelines show significant benefits of FUZEON for wide range of pre-treated HIV/AIDS patients

New international consensus guidelines for FUZEON (enfuvirtide) are published today in AIDS, the official journal of the International AIDS Society. These guidelines are vital because they balance the significant benefits of FUZEON with the need for self-injection and also provide a clear framework for FUZEON use.

The independent consensus panel of nine leading experts from around the world agreed that:

  • FUZEON represents an important advance in HIV therapy
  • With ongoing training and support, healthcare professionals can assist patients in successfully introducing FUZEON into their daily routines
  • FUZEON benefits pre-treated patients across all sub-groups studied, including those taking few or no other active drugs
  • Optimal outcomes are achieved when FUZEON is used in patients who have a higher CD4 count (> or equal to 100 versus < or equal to 100 cells/mm)
  • An initial investment in establishing patient training programmes yield significant returns in the maintenance of adherence, patient confidence, and in the benefit of FUZEON therapy

"FUZEON is an important treatment for the increasing number of patients with HIV drug resistance. By providing clear advice on timing of FUZEON initiation and patient support during therapy, these guidelines clarify the place of this breakthrough drug in current HIV treatment regimens and will enable more pre-treated patients to benefit," stated Dr Mike Youle, Royal Free Hospital, London.

Mr Colin Webb, Executive Director of European Coalition of Positive People (ECPP) commented, "The ECPP welcomes these international consensus guidelines for FUZEON. They are important as they encourage further dialogue between physicians and their patients, ensuring that informed decisions are made on when to consider and successfully introduce FUZEON."


'"/>

Contact: Amanda Boswell
amanda.boswell@ketchum.com
44-207-611-3571
Ketchum
16-May-2004


Page: 1

Related biology news :

1. International critical care doctors release first-ever guidelines for sepsis
2. Revised guidelines published for testing for hereditary type of colorectal cancer
3. New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes
4. Ethical guidelines needed before nutrigenomic groceries come to market
5. New guidelines can help health officials better predict and control dengue epidemics
6. Researchers develop guidelines to establish identity of genes responsible for complex diseases
7. Aborigine study suggests body mass index guidelines should be lower to block diabetes
8. New nutrition guidelines for diabetics promote emphasis on high-monounsaturated fat diet
9. Conservation International and Starbucks announce new coffee sourcing guidelines
10. Report on dietary supplements containing ephedra makes urgent call for research to develop dose guidelines, safety warnings
11. Current HIV treatment guidelines may result in more men than women being eligible for treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 14, 2019 , ... ... explore how developments in microbiome therapeutics are helping to promote normal immune function ... information. , Advancements will educate about the DECODE.DESIGN.CURE™ technology platform, which rapidly develops ...
(Date:8/14/2019)... TORONTO (PRWEB) , ... August 13, 2019 , ... ... Cancer Medicine Team, Division of Molecular Pathology, Institute of Cancer Research (ICR) in ... (5pm BST/UK) to learn about the process of biomarker and companion diagnostic development ...
(Date:8/6/2019)... ... August 05, 2019 , ... Keck Graduate Institute (KGI) President ... Pharmacy and Health Sciences (SPHS). , “Dean Zdanowicz is highly regarded as an innovative ... Jim Widergren. “He is a great choice to build on the success of the ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 10, 2019 , ... ... and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local ... Group) and will educate viewers about how its technology facilitates laboratories to improve ...
(Date:6/11/2019)... Md. and ROANOKE, Va. (PRWEB) , ... June ... ... care optimized for microlearning engagement, and Carilion Clinic, a national leader in opioid ... the latest in virtual care. , Mytonomy recently deployed its virtual ...
(Date:6/11/2019)... N.C. (PRWEB) , ... June 11, 2019 , ... ... extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate ... cloning ability. In a test on mice, MSC-EVs also increased the cells’ ability ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
Breaking Biology Technology:
Cached News: